Immunic, Inc.(NASDAQ:IMUX), a late-stage biotechnology company pioneering the development of novel o

Immunic (IMUX) stock rises premarket to $13.14 as the company names former Genentech executive Erik

B. Riley Securities analyst William Woods maintains Immunic (NASDAQ:IMUX) with a Buy and lowers t

Mr. Bonney brings more than three decades of leadership experience in the biopharmaceutical industry

Immunic (NASDAQ:IMUX) reported quarterly losses of $(1.08) per share which missed the analyst consen

Top Wall Street analysts changed their outlook on top names. See all rating changes at https://www.b

HC Wainwright & Co. analyst Matthew Caufield maintains Immunic (NASDAQ:IMUX) with a Buy and r

Immunic appoints Michael Panzara as CMO, granting inducement equity award as he takes charge of clin

Immunic, Inc. (NASDAQ:IMUX), a late-stage biotechnology company pioneering the development of novel

Stifel initiates coverage on Immunic (IMUX) with a Buy rating. Analysts see potential for VidoCa to

Stifel analyst Paul Matteis initiates coverage on Immunic (NASDAQ:IMUX) with a Buy rating and ann

Top Wall Street analysts changed outlook on top names. See all rating changes at https://www.benzing

Guggenheim analyst Yatin Suneja initiates coverage on Immunic (NASDAQ:IMUX) with a Buy rating and

Wall Street analysts changed outlook on top names: BTIG cut CRWD PT, Piper Sandler cut BSY PT, RBC C

HC Wainwright & Co. analyst Matthew Caufield maintains Immunic (NASDAQ:IMUX) with a Buy and l

Immunic (NASDAQ:IMUX) reported quarterly losses of $(0.07) per share which beat the analyst consensu

Immunic stock surges on oversubscribed private placement raising $400 million to accelerate commerci

Immunic Inc (NASDAQ:IMUX) is surging Friday after the late‑stage biotech announced a private placeme

D. Boral Capital analyst Jason Kolbert maintains Immunic (NASDAQ:IMUX) with a Buy and lowers the

HC Wainwright & Co. analyst Matthew Caufield reiterates Immunic (NASDAQ:IMUX) with a Buy and

Additional CALLIPER MRI Analyses Show Reductions for Vidofludimus Calcium in Acute and Chronic Infla

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analys

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analys

Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is likely to report quarterly earnings

Companies Reporting Before The Bell • CureVac (NASDAQ:CVAC) is likely to report quarterly loss at $

Gainers SuperCom Ltd. (NASDAQ: SPCB) shares jumped 89% to $0.6805, after falling 13% on Monday.

Gainers SuperCom Ltd. (NASDAQ: SPCB) shares rose 78.4% to $0.6425 in pre-market trading, after fal

Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is likely to report quarterly earnings

Companies Reporting Before The Bell • ChipMOS TECHNOLOGIES (NASDAQ:IMOS) is likely to report earnin

  Wednesday saw 219 companies set new 52-week lows.

  Tuesday's session saw 167 companies set new 52-week lows.

  On Monday, 160 companies hit new 52-week lows.

  Friday's session saw 236 companies set new 52-week lows.

Companies Reporting Before The Bell • Hyatt Hotels (NYSE:H) is estimated to report quarterly earnin

  On Monday, 413 companies reached new 52-week lows.

Gainers Huadi International Group Co., Ltd. (NASDAQ: HUDI) jumped 89.3% to close at $58.92 on Fri

Upgrades

Gainers Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) rose 43.2% to $0.2097 in pre-market tr

Gainers FedNat Holding Company (NASDAQ: FNHC) shares climbed 107.7% to close at $0.3395 on Tuesda